AN2 Therapeutics (ANTX) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

AN2 Therapeutics (ANTX) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: September 30, 2023 (11:07)

Sector: Healthcare

The share price of AN2 Therapeutics, Inc. (ANTX) now

What analysts predict: $24
52-week High/Low: $21.04 / $4.87

50/200 Day Moving Average: $9.58 / $9.46

This figure corresponds to the Average Price over the previous 50/200 days. For AN2 Therapeutics stocks, the 50-day moving average is the support level today.

For AN2 Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in AN2 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the AN2 Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one AN2 Therapeutics share be worth in 2023 - 2027?

When should I take profit in AN2 Therapeutics stock? When should I record a loss on AN2 Therapeutics stock? What are analysts' forecasts for AN2 Therapeutics stock? What is the future of AN2 Therapeutics stock? We forecast AN2 Therapeutics stock performance using neural networks based on historical data on AN2 Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

AN2 Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for AN2 Therapeutics shares. This happens once a day.




Historical and forecast chart of AN2 Therapeutics stock

The chart below shows the historical price of AN2 Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AN2 Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

AN2 Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 02 16.21 15.87 16.47 3.78
Oct 03 16.10 15.91 16.31 2.49
Oct 04 16.27 16.13 16.62 2.99
Oct 05 16.02 15.91 16.35 2.77
Oct 06 15.84 15.61 15.93 2.03
Oct 07 16.11 15.83 16.41 3.65
Oct 08 15.90 15.70 16.15 2.87
Oct 09 16.02 15.67 16.24 3.64
Oct 10 16.34 16.24 16.55 1.90
Oct 11 16.19 16.03 16.41 2.37
Oct 12 15.97 15.87 16.29 2.66
Oct 13 15.95 15.79 16.12 2.10
Oct 14 15.97 15.77 16.16 2.46
Oct 15 15.91 15.67 16.14 3.04
Oct 16 16.23 15.96 16.55 3.71
Oct 17 16.26 16.02 16.37 2.19
Oct 18 16.48 16.33 16.59 1.61
Oct 19 16.55 16.44 16.78 2.07
Oct 20 16.54 16.37 16.88 3.14
Oct 21 16.50 16.31 16.67 2.16
Oct 22 16.45 16.27 16.68 2.48
Oct 23 16.55 16.36 16.79 2.65
Oct 24 16.65 16.52 16.89 2.20
Oct 25 16.97 16.66 17.28 3.74
Oct 26 17.40 17.24 17.57 1.88
Oct 27 17.74 17.41 18.02 3.49
Oct 28 17.41 17.15 17.61 2.71
Oct 29 17.19 16.82 17.37 3.26
Oct 30 16.86 16.65 16.97 1.94
Oct 31 16.92 16.68 17.16 2.88

AN2 Therapeutics Daily Price Targets


AN2 Therapeutics Stock Forecast 10-02-2023.

Forecast target price for 10-02-2023: $16.21.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.640%.
Pessimistic target level: 15.87
Optimistic target level: 16.47

AN2 Therapeutics Stock Forecast 10-03-2023.

Forecast target price for 10-03-2023: $16.10.
Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.426%.
Pessimistic target level: 15.91
Optimistic target level: 16.31

AN2 Therapeutics Stock Forecast 10-04-2023.

Forecast target price for 10-04-2023: $16.27.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.907%.
Pessimistic target level: 16.13
Optimistic target level: 16.62

AN2 Therapeutics Stock Forecast 10-05-2023.

Forecast target price for 10-05-2023: $16.02.
Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 2.697%.
Pessimistic target level: 15.91
Optimistic target level: 16.35

AN2 Therapeutics Stock Forecast 10-06-2023.

Forecast target price for 10-06-2023: $15.84.
Negative dynamics for AN2 Therapeutics shares will prevail with possible volatility of 1.987%.
Pessimistic target level: 15.61
Optimistic target level: 15.93

AN2 Therapeutics Stock Forecast 10-07-2023.

Forecast target price for 10-07-2023: $16.11.
Positive dynamics for AN2 Therapeutics shares will prevail with possible volatility of 3.526%.
Pessimistic target level: 15.83
Optimistic target level: 16.41

ANTX (ANTX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Oct. 15.91 15.41 16.71 7.77
Nov. 16.90 15.97 17.79 10.26
Dec. 16.86 16.34 17.37 5.98

AN2 Therapeutics forecast for this year


AN2 Therapeutics Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $15.9089. Pessimistic: $15.41. Optimistic: $16.71


AN2 Therapeutics Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $16.9016. Pessimistic: $15.97. Optimistic: $17.79


AN2 Therapeutics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $16.8611. Pessimistic: $16.34. Optimistic: $17.37



AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 16.21 15.21 16.52 7.93
Feb 15.94 15.48 16.26 4.78
Mar 16.96 15.93 17.38 8.35
Apr 16.35 15.38 17.29 11.04
May 16.06 15.36 16.35 6.05
Jun 16.63 15.70 17.15 8.46
Jul 17.00 16.31 17.89 8.82
Aug 17.31 16.37 17.66 7.29
Sep 16.18 15.83 16.79 5.71
Oct 16.41 15.51 17.13 9.50
Nov 15.79 15.05 16.36 8.03
Dec 16.78 16.39 17.44 6.00

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 16.90 16.12 17.21 6.36
Mar 17.36 16.58 17.92 7.44
Mar 17.17 16.14 17.92 9.96
Apr 17.67 16.57 18.04 8.15
May 17.83 17.20 18.63 7.66
Jun 16.92 16.35 17.66 7.43
Jul 16.27 15.36 17.13 10.33
Aug 16.67 15.87 17.58 9.71
Sep 17.30 16.59 18.38 9.71
Oct 17.99 17.37 18.65 6.87
Nov 18.02 16.86 18.75 10.07
Dec 19.30 18.81 20.30 7.38

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 17.85 16.98 18.55 8.47
Mar 16.51 16.06 17.51 8.30
Mar 17.07 16.15 17.66 8.58
Apr 16.02 15.37 16.48 6.77
May 16.46 15.79 17.20 8.19
Jun 17.20 16.47 18.04 8.70
Jul 18.50 17.33 19.48 11.02
Aug 17.85 17.12 18.94 9.58
Sep 18.68 17.99 19.13 5.94
Oct 18.89 17.95 19.33 7.12
Nov 20.35 19.87 21.17 6.15
Dec 21.02 19.96 21.43 6.83

AN2 Therapeutics (ANTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 20.23 19.81 21.12 6.21
Mar 19.71 19.10 20.91 8.67
Mar 18.97 17.76 20.17 11.96
Apr 19.53 18.99 20.47 7.25
May 20.28 19.33 20.92 7.60
Jun 20.84 19.87 21.44 7.31
Jul 20.55 20.09 20.93 4.01
Aug 20.13 19.18 20.90 8.24
Sep 21.01 20.56 21.65 5.05
Oct 22.29 21.47 23.22 7.53
Nov 22.24 20.92 23.46 10.84
Dec 23.69 23.24 24.15 3.77

AN2 Therapeutics information and performance

AN2 is developing treatments for rare, chronic, and serious infectious diseases. Its initial product candidate is epetraborole, a once-daily oral drug that aims to treat chronic nontuberculous mycobacterial lung disease.
The biotech is the second company to open for trading in March. The first was Akanda (ticker: AKAN), a medical-cannabis company, which listed its shares on March 15, soaring 163% in its debut. Akanda stock is down about 18% from the $10.50 first-day closing price but still up 116% from the $4 IPO price.

AN2 Therapeutics Address

1800 EL CAMINO REAL, SUITE D, MENLO PARK, CA, US

Market Capitalization: 453 020 000 $

Market capitalization of the AN2 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ANTX shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA of AN2 Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.49

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.338

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 29706200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.